- Supported exchanges /
- KQ /
- 102940.KQ
Kolon Life Science Inc (102940 KQ) stock market data APIs
Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, pyrithione antimicrobials, and water solutions primarily in South Korea. Its biopharmaceutical product under development comprise KLS-1020, a cancer vaccine; KLS-3021, a oncolytic viral therapy; and KLS-2031 for treatment for neuropathic pain. The company also provides active pharmaceutical ingredients for anti-cancer and intermediates; and pyrithione antimicrobial for shampoo and soap bars, cosmetic and wet wipes, fabric softeners, metalworking fluids, antifouling paints, and fire-fighters. In addition, it offers Kolon BESFLOC polymer used in chemical, food, leather, pharmaceutical, textile, and dairy industries, as well as in settling reservoirs, sludge thickeners, floating reservoirs, and dehydrators in sewage treatment plants. The company was formerly known as Korea Tissuegene Asia, Ltd. and changed its name to Kolon Life Science Inc. in January 2006. Kolon Life Science Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Kolon Life Science Inc Financial Data Overview
| 18000 | |
| 17790 | |
| - | |
| 18110 | |
| 17600 | |
| 16780-31000 | |
| 221 350 M | |
| 11 408 K | |
| 190 606 M | |
| 1.1303 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Kolon Life Science Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 190 606 M
- EBITDA 11 625 M
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Kolon Life Science Inc Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Kolon Life Science Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
